Shanghai - Delayed Quote CNY

Cathay Biotech Inc. (688065.SS)

47.20
-0.34
(-0.72%)
At close: 3:00:03 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
693,142.19
820,929.33
569,451.27
803,673.72
578,685.81
Operating Cash Flow
--
820,929.33
569,451.27
803,673.72
578,685.81
Investing Cash Flow
-665,058.51
-823,060.90
-1,558,809.73
-4,198,216.07
-110,756.12
Financing Cash Flow
5,786,429.95
149,491.98
-262,160.31
403,878.41
2,987,449.23
End Cash Position
10,609,731.64
5,185,964.71
5,013,779.56
6,225,077.24
9,155,757.83
Capital Expenditure
-659,810.78
-843,313.17
-1,569,780.68
-4,198,356.50
-1,459,176.92
Issuance of Debt
1,490,972.08
1,692,844.09
937,023.69
1,126,469.94
798,080
Repayment of Debt
-1,512,646.46
-1,570,030.60
-289,769.94
-740,000
-55,000
Free Cash Flow
33,331.41
-22,383.84
-1,000,329.41
-3,394,682.77
-880,491.11
12/31/2021 - 8/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers